UK 13:56 Monday, 26 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
This is a bolt from the blue. Regent Pacific a HK and Frankfurt listed investment company run by my good friend Jim Mellon has today announced an all paper offer for AIM listed Plethora (PLE) at 12.5p a share. But hang on, the devil is in the detail.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments
Analyst
The difference between Jim’s outfit and other small pharma/biotechs is that the drug PSD502 has already been proven to work at phase III. PLE just has to raise enough cash for the regulatory stuff/marketing so it can be sold.
It is a fair offer for the company. But ISA holders can not keep foreign shares in their account.
Catempire
Anaylist – except the product is poor mans coke in a spray …
If this product was even needed (baring in mind it only helps someone last a few seconds longer) do you not think the little blue pill makers would have been all over it some time ago… Oh wait they kind of were because Viagra also makes people last longer.
There are pills being developed ATM for this very purpose…
Can you really see a little spray with poor mans coke in you spray on the end of your bellend taking off as a product ?..
Regardless of it’s got the all clear from EU who in their right mind will use it ?… The ideas good, the products terible!
I know the company very well as I was in from 2p before the pump and mark my words no matter what happens here JM won’t lose any money, it’s a safe bet, for him and for him only!
Czech Mate (aka Janos)
ISA holders most certainly CAN keep foreign shares in their account.
The only condition (roughly speaking) is that the shares are listed on a recognised stock exchange.
https://www.gov.uk/guidance/recognised-stock-exchanges
James
Its a shrewd move, it takes out the 15 warrants and confirms that the reduced fill issue is resolved – why else would RP buy out the royalties for £2.4 million a few months ago and now offer 12.5 p in stock. Ple spiked at 20 p on the back of the Recordati deal and we know that two further licensing deals are already line up pending variation approval on the cannister size. Add to that potential in US and Asia and RP will be getting this on the cheap.
Camptire – you need to look at the medical read outs and do a little basic research before making such silly comments.